Insuring the Future: The Financing of Health Care

	Sponsored by:

Presented by: School of Business Administration
As the dust settles after the contentious debate over historic health care reform legislation, and its ultimate passage, all eyes are on implementation. This panel will delve into the complexities involved in expanding coverage and reveal how various industry sectors will be impacted, the opportunities that will arise for them, and how they may respond. Panelists will address the impact of health care reform on the finances of health care insurers and providers, and propose innovative approaches to improve the efficiency, quality, financing, and provision of care.

• Richard L. Clarke, President and CEO, Healthcare Financial Management Association (HFMA)
• Michael J. Tuffin, Executive Vice President, America's Health Insurance Plans (AHIP)

• Richard J. Umbdenstock, President and CEO, American Hospital Association

• Cecil B. Wilson, MD, President, American Medical Association
• Donna E. Shalala, President, University of Miami (moderator)
• Jon R. Cohen, M.D., Senior Vice President and Chief Medical Officer, Quest Diagnostics (welcome remarks)
• Patrick K. Barron, President, University of Miami Alumni Association; First Vice President and Chief Operating Officer, Federal Reserve Bank of Atlanta; University of Miami Trustee (introduction)

Managing Conflict of Interest:  The Patient-Centric View

*Signature Plenary Panel Session

	Sponsored by:

Presented by: Miller School of Medicine
In the recent past, the regulatory climate for interaction between doctors and industry has changed markedly. The new regulations have increased transparency in doctor-industry relations and have reduced conflicts of interest and thus potential risk to patients. Yet it remains true that the development of drugs, devices and therapeutic strategies requires careful and non-conflicted interaction between industry and clinicians. Preventing such interaction entirely could block the development of new technologies that have the potential to save patients' lives. This panel of experts, from top industry executives to academic thought leaders, will review these issues and explore the possibility of creating a new partnership focused on a patient-centric model. This panel will specifically focus on what can be done to optimize the patient centricity of industry-doctors interaction, for the effective development of drugs, devices and other therapeutics, while managing conflict of interest, with the ultimate goal of providing patients with the best opportunity for health and wellness.    

• John Capek, Executive Vice President, Medical Devices, Abbott Labs

• Jon R. Cohen, MD, Senior Vice President and Chief Medical Officer, Quest Diagnostics

• William A. Hawkins, CEO, Medtronic Inc.

• William O'Neill, MD, Executive Dean for Clinical Affairs, Miller School of Medicine, University of Miami
• Richard S. Stack, Managing General Partner, Synecor LLC

• Peter van der Goes, Jr., Managing Director, Healthcare Banking, Goldman Sachs
• Thomas P. Stossel, MD, Director, Translational Medicine Division,  Brigham and Women's Hospital, Harvard Medical School

• Pascal J. Goldschmidt, MD, Dean, Miller School of Medicine, University of Miami (moderator)
• Steven G. Ullmann, Professor, Management and Director, Programs in Health Sector Management and Policy, School of Business Administration, University of Miami (opening remarks)

Coping with a New Landscape of FDA Regulations:  The Patient-Centric View

	Sponsored by:

Presented by: Miller School of Medicine
In the recent past, the regulatory climate for interaction between doctors and industry has changed markedly. The new regulations have increased transparency in doctor-industry relations and have reduced conflicts of interest and thus potential risk to patients. Yet it remains true that the development of drugs, devices and therapeutic strategies requires careful and non-conflicted interaction between industry and clinicians.  Preventing such interaction entirely could block the development of new technologies that have the potential to save patients' lives. This panel of experts, from top industry executives to academic thought leaders, will review these issues and explore the possibility of creating a new partnership focused on a patient-centric model. Panelists will address the challenge of conducting clinical research, and in preserving the leadership of the U.S. in therapeutics development, and also in keeping research jobs in the U.S., while facing a new regulatory landscape. Experts from industry and academic medicine will present expert view points on how this can be done with a sharp focus on patients' wellness and health.

• William O'Neill, MD, Executive Dean for Clinical Affairs, Miller School of Medicine, University of Miami

• Jon R. Cohen, MD, Senior Vice President and Chief Medical Officer, Quest Diagnostics

• William A. Hawkins, CEO, Medtronic Inc.

• Richard S. Stack, Managing General Partner, Synecor LLC

• John Capek, Executive Vice President, Medical Devices, Abbott Labs

• Peter van der Goes, Jr., Managing Director, Healthcare Banking, Goldman Sachs
• Thomas P. Stossel, MD, Director, Translational Medicine Division,  Brigham and Women's Hospital, Harvard Medical School

• Pascal J. Goldschmidt, MD, Dean, Miller School of Medicine, University of Miami (moderator)

Health Care Fraud’s Ground Zero: South Florida

	Sponsored by:

Presented by: School of Business Administration
The National Health Care Anti-Fraud Association estimates that each year more than $60 billion, or 3% of the nation's health care spending, is lost to fraud.  South Florida is ground zero for such fraud with more than 700 indictments and more than 500 arrests and convictions since 2007 – far exceeding every other market in the nation. This panel will provide insight into the depth of the problem, the impact on legitimate providers and consumers, and offer solutions for safeguarding organizations from falling victim to fraud and abuse.

• John V. Gillies, Special Agent in Charge (SAC), Miami Division, Federal Bureau of Investigation (FBI)
• Wifredo Ferrer, U.S. Attorney, Southern District of Florida

• Cecilia Franco, Miami Field Office Director, Centers for Medicare and Medicaid Services (CMS)

• Brian Keeley, President and CEO, Baptist Health South Florida (moderator)

Health Care Entrepreneurs in a Changing Environment

Presented by: The Launch Pad
The health sector has always been marked by rapid change. But today, in the face of health care reform, the industry is being transformed at lightning speed and at every level. This panel will examine what this rapidly changing marketplace means for health care entrepreneurs using current case studies and examples from the past. Business executives, representatives of venture-backed firms and insurance professionals will participate in this exciting exchange of ideas.

• Kevin Hutchinson, Entrepreneurial Executive; Former CEO, Prematics and Surescripts; and Former COO, MedicaLogic / Medscape (MDLI)
• Anthony Masso, Former President and CEO, Consortium Health Plans
• David McLean, CEO, NovoLogix
• William Scott Green, Senior Vice Provost and Dean of Undergraduate Education, University of Miami (moderator)

Employee Benefits/Employer Challenges: Managing Employer Health Care Costs Under Health Care Reform and in a Competitive Global Environment

Presented by: School of Business Administration

The ability of firms to provide health care benefits has become increasingly more difficult. High costs, coupled with the realization that firms must lower cost structures to compete globally, makes the task of health benefit management daunting.  This panel will examine how health care reform may affect the ability of firms to compete and reveal who will benefit and who will be burdened. The session will also explore whether new arrangements among providers, insurers, employers, employees and the government will be needed.

• Jack Bailey, Senior Vice President, Public and Private Institutional Customers, GlaxoSmithKline
• J. Randall MacDonald, Senior Vice President, Human Resources, IBM
• Ken Sperling, Health Care Practice Leader, Aon Hewitt

• William Werther, Professor of Management, School of Business Administration, University of Miami (moderator)

Patient-Centered Care and Accountable Care Organizations in an Era of Health Care Reform

Presented by: School of Business Administration

	Sponsored by:

The accountable care organization is touted as an innovative model for health care reform. This discussion will revolve around the integration of insurance, hospital and physician service functions, with the ultimate aim of improving the quality of care and quality of life of the patient.

• John Bigalke, Vice Chairman and U.S. National Industry Leader, Health Sciences & Government, Deloitte LLP
• Delos M. Cosgrove, MD, President and CEO, Cleveland Clinic
• Stephen K. Jones, President and CEO, Robert Wood Johnson University Hospital
• Anthony Rodgers, Deputy Administrator, Center for Strategic Planning, Centers for Medicare and Medicaid Services (CMS), U.S. Department of Health and Human Services
• John M. Kirsner, Partner, Squire, Sanders & Dempsey LLP (moderator)

Security and Innovation in Health Information Technology (IT)

Presented by: School of Business Administration
This panel will address the latest security and technology trends in health IT and what organizations should be prepared for today and in the future. Panelists will reveal new technologies on the horizon and offer insight into future trends. This session will also explore best practices that enhance the protection of health information and provide better patient care.

• Gary Bahadur, CEO, KRAA Security
• Mark N. Blatt, MD, Director, Healthcare Industry Solutions, Digital Health Group, Intel Corporation
• Chris S. Davenport, Global Security Consultant - Healthcare, IBM Global Business Solutions
• Michael A. Salzhauer, MD, Board Certified Plastic Surgeon, Bal Harbour Plastic Surgery
• Albert Santalo, President and CEO, CareCloud
• Bill Taylor, President, Panasonic System Networks Company of America
• Sara Rushinek, Professor, Computer Information Systems Department, School of Business Administration, University of Miami (moderator)

Commercializing Medical Devices: A View From the Trenches

Presented by: School of Business Administration Entrepreneurship Programs
In this panel session, serial entrepreneurs who have played an integral part of taking multiple startup firms from nothing to extremely successful exits will provide an inside view of the medical device commercialization process. Panelists will discuss all aspects of the commercialization process, from discovery and clinical trials through fundraising, marketing, and exit. They will also give their perspective on future technological advances in this critical and dynamic clinical space.

• Fred Khosravi, Managing Director, Incept LLC; Founder and Chairman, Access Closure

• Christopher M. Owens, President and CEO, IDEV Technologies Inc.
• Duke Rohlen, Founder and CEO, CV Ingenuity
• Stacy Enxing Seng, Executive Vice President and President, WW Peripheral Vascular, ev3/Covidien
• Barry S. Weinstock, MD, Mid-Florida Cardiology Specialists (moderator)